4D Molecular Therapeutics holders back 2026 proposals
4D Molecular Therapeutics, Inc. reported the results of its 2026 Annual Meeting of Stockholders.
Rhea-AI Filing Summary
4D Molecular Therapeutics, Inc. reported the results of its 2026 Annual Meeting of Stockholders. As of the record date on April 20, 2026, there were 52,274,735 common shares outstanding, and 44,038,022 shares were represented in person or by proxy at the meeting.
Stockholders elected Class III directors Nancy Miller-Rich, John F. Milligan, Ph.D., and Shawn Cline Tomasello, MBA to serve until the 2029 Annual Meeting or until their successors are elected. Votes for these nominees ranged from 30.5 million to 35.9 million, with additional broker non-votes recorded.
Stockholders also ratified the appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 43,900,362 votes for. In an advisory vote, stockholders approved the compensation of named executive officers, with 36,065,437 votes for and 940,414 against.
8-K Event Classification
Item 5.07 — Submission of Matters to a Vote of Security Holders
1 item
Item 5.07
Submission of Matters to a Vote of Security Holders
Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Key Figures
Shares outstanding: 52,274,735 shares
Shares represented: 44,038,022 shares
Votes for PwC ratification: 43,900,362 votes
+5 more
8 metrics
Shares outstanding
52,274,735 shares
Common stock outstanding as of April 20, 2026 record date
Shares represented
44,038,022 shares
Shares voted in person or by proxy at 2026 Annual Meeting
Votes for PwC ratification
43,900,362 votes
Ratification of PricewaterhouseCoopers LLP as auditor for 2026
Say-on-pay support
36,065,437 votes for
Advisory approval of named executive officers’ compensation
Broker non-votes
6,964,792 shares
Broker non-votes on director and compensation proposals
Votes for Nancy Miller-Rich
35,880,028 votes
Election as Class III director
Votes for John F. Milligan
35,778,121 votes
Election as Class III director
Votes for Shawn Cline Tomasello
30,508,706 votes
Election as Class III director
Key Terms
broker non-votes, independent registered public accounting firm, advisory, non-binding basis, Annual Meeting of Stockholders, +1 more
5 terms
broker non-votes financial
"BROKER NON-VOTES 6,964,792"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.
independent registered public accounting firm financial
"ratified the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
advisory, non-binding basis financial
"approved, on an advisory, non-binding basis, the named executive officers’ compensation"
Annual Meeting of Stockholders financial
"held its 2026 Annual Meeting of Stockholders virtually via the internet"
Class III director financial
"elected by a plurality of votes cast the Class III director nominees"
A Class III director is a board member placed in one of the numbered groups used by companies with a staggered (or “classified”) board; that director’s seat typically comes up for election in the third year of a three-year rotation. For investors this matters because staggered terms create continuity but also make it harder to replace the whole board quickly, affecting shareholder influence, takeover dynamics and how fast new strategy or accountability can be implemented — like replacing only some players on a sports team each season instead of the whole roster at once.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did 4D Molecular Therapeutics (FDMT) stockholders vote on at the 2026 annual meeting?
Stockholders voted on electing three Class III directors, ratifying PricewaterhouseCoopers LLP as auditor for 2026, and approving executive compensation on an advisory basis. All three proposals received the required support and were approved at the meeting.
Were the director nominees elected at 4D Molecular Therapeutics’ 2026 annual meeting?
Yes. Class III director nominees Nancy Miller-Rich, John F. Milligan, Ph.D., and Shawn Cline Tomasello, MBA were elected by a plurality of votes cast. They will serve until the 2029 Annual Meeting of Stockholders or until their successors are elected.
Did 4D Molecular Therapeutics (FDMT) stockholders approve the 2026 auditor ratification?
Yes. Stockholders ratified the selection of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 43,900,362 votes for, 55,763 votes against, and 81,897 abstentions recorded.
How did 4D Molecular Therapeutics stockholders vote on executive compensation in 2026?
Stockholders approved, on an advisory and non-binding basis, the compensation of named executive officers. The vote totaled 36,065,437 shares for, 940,414 against, 67,379 abstentions, and 6,964,792 broker non-votes, indicating overall support for the compensation program.
What are broker non-votes in the 4D Molecular Therapeutics (FDMT) 2026 voting results?
Broker non-votes occur when brokers hold shares in street name but lack instructions to vote on certain proposals. In this meeting, broker non-votes were reported on director elections and the executive compensation advisory vote, totaling 6,964,792 shares in each of those proposals.
AI-generated analysis. How Rhea-AI works. Not financial advice.
